Uncategorized

The second video in the series developed by the project team is now available and explains what a clinical study is Also presented by Dr Guillaume Marquis-Gravel, this 2nd video explains in simple terms what a clinical study is and the concepts related to safety… Read More »The second video in the series developed by the project team is now available and explains what a clinical study is.

CBC radio show: Interview with Ecogène-21 – News on the drone delivery project (Interview is available exclusively in French) Résumé Au menu de l’émission : peut-on envisager une reconnaissance patrimoniale et historique du secteur de Port-Alfred semblable à celle du village historique de Val-Jalbert? Le citoyen Andy… Read More »CBC radio show: Interview with Ecogène-21 – News on the drone delivery project

Dr. Jean-Claude Tardif is the winner of the Michel Sarrazin Prize from the Club de Recherches Cliniques du Québec (CRCQ) Jean-Claude Tardif, Prix Michel-Sarrazin 2023 (This article is available exclusively in French) Remis depuis 1977, le prix Michel-Sarrazin honore une ou un scientifique québécois chevronné… Read More »Dr. Jean-Claude Tardif is the winner of the Michel Sarrazin Prize from the Club de Recherches Cliniques du Québec (CRCQ)

A short video has been developed by the project team to explain what research consent entails Presented by Dr. Guillaume Marquis-Gravel, cardiologist and researcher at the Montreal Heart Institute, this video defines the concepts of informed, voluntary, and ongoing consent. Additionally, it informs potential participants… Read More »A short video has been developed by the project team to explain what research consent entails

Jean-Claude Tardif is the winner of the Desmond Julian Prize from the European Heart Journal (This article is available exclusively in French) Le Dr Jean-Claude Tardif, directeur du Centre de recherche de l’Institut de cardiologie de Montréal et professeur titulaire de médecine à l’Université de Montréal,… Read More »Jean-Claude Tardif is the winner of the Desmond Julian Prize from the European Heart Journal

Article by Karim Aly, CEO of our partner Noze – AI Powered Breath Analysis for Early Disease Screening & Diagnostics Most people would likely agree that the healthcare industry is in need of a good shakeup, particularly in the domains of disease screening and diagnostics.… Read More »Article by Karim Aly, CEO of our partner Noze – AI Powered Breath Analysis for Early Disease Screening & Diagnostics

Noze’s blog on how smell will redefine healthcare Smell has been used as a powerful tool in disease diagnostics by humans for centuries. Ancient Greek and Chinese civilizations used it to detect infectious diseases like tuberculosis. Soldiers on battlefields, ripe with conditions for the development of flesh-eating… Read More »Noze’s blog on how smell will redefine healthcare

Our partner Noze has been ranked among the top 100 Canadian startups. We are proud of our achievements and honored to be among other leading Canadian businesses. Find out what other companies are on the list here: https://hubs.la/Q01xw1T80 READ FULL ARTICLE HERE

Blog – Dr. Marie-Pierre Dubé, director of the MHI’s Pharmacogenomics Centre, a project partner, talks about precision medicine. A real math and biology whiz, Dr. Dubé first developed a keen interest in genetics during university. “I fell in love with genetics. I saw it as… Read More »Blog – Dr. Marie-Pierre Dubé, director of the MHI’s Pharmacogenomics Centre, a project partner, talks about precision medicine.

A study from the Montreal Heart Institute, led by Dr. Tardif, principal investigator of our project, is behind the approval of colchicine in the United States. THIS ARTICLE IS AVAILABLE EXCLUSIVELY IN FRENCH La FDA des États-Unis a approuvé la semaine dernière la colchicine à… Read More »A study from the Montreal Heart Institute, led by Dr. Tardif, principal investigator of our project, is behind the approval of colchicine in the United States.